Touro Scholar
Faculty Publications & Research of the TUC
College of Pharmacy

College of Pharmacy

2016

Pseudomonas Aeruginosa Outer Membrane Vesicles Triggered by
Human Mucosal Fluid and Lysozyme Can Prime Host Tissue
Surfaces for Bacterial Adhesion
Matteo M. E. Metruccio
David J. Evans
Touro University California, david.evans@tu.edu

Manal M. Gabriel
Jagath L. Kadurugamuwa
Suzanne M. J. Fleiszig

Follow this and additional works at: https://touroscholar.touro.edu/tuccop_pubs
Part of the Bacterial Infections and Mycoses Commons

Recommended Citation
Metruccio, M. M. E., Evans, D. J., Gabriel, M. M., Kadurugamuwa, J. L., & Fleiszig, S. M. J. (2016).
Pseudomonas aeruginosa outer membrane vesicles triggered by human mucosal fluid and lysozyme can
prime host tissue surfaces for bacterial adhesion. Frontiers in Microbiology, 7 [Article 00871].

ORIGINAL RESEARCH
published: 03 June 2016
doi: 10.3389/fmicb.2016.00871

Pseudomonas aeruginosa Outer
Membrane Vesicles Triggered by
Human Mucosal Fluid and Lysozyme
Can Prime Host Tissue Surfaces for
Bacterial Adhesion
Matteo M. E. Metruccio 1 , David J. Evans 1,2 , Manal M. Gabriel 3 ,
Jagath L. Kadurugamuwa 4 and Suzanne M. J. Fleiszig 1,5*
1

School of Optometry, University of California, Berkeley, CA, USA, 2 College of Pharmacy, Touro University California, Vallejo,
CA, USA, 3 Alcon Research, Ltd., Johns Creek, GA, USA, 4 Alcon Research, Ltd., Fort Worth, TX, USA, 5 Graduate Groups in
Vision Science, Microbiology, and Infectious Diseases and Immunity, University of California, Berkeley, CA, USA

Edited by:
Yuji Morita,
Aichi Gakuin University, Japan
Reviewed by:
Mihaela Gadjeva,
Harvard Medical School, USA
Bart Devreese,
Ghent University, Belgium
Cezar M. Khursigara,
University of Guelph, Canada
Laura Baldomà,
Universitat de Barcelona, Spain
*Correspondence:
Suzanne M. J. Fleiszig
fleiszig@berkeley.edu
Specialty section:
This article was submitted to
Infectious Diseases,
a section of the journal
Frontiers in Microbiology
Received: 14 March 2016
Accepted: 23 May 2016
Published: 03 June 2016
Citation:
Metruccio MME, Evans DJ, Gabriel
MM, Kadurugamuwa JL and Fleiszig
SMJ (2016) Pseudomonas
aeruginosa Outer Membrane Vesicles
Triggered by Human Mucosal Fluid
and Lysozyme Can Prime Host Tissue
Surfaces for Bacterial Adhesion.
Front. Microbiol. 7:871.
doi: 10.3389/fmicb.2016.00871

Pseudomonas aeruginosa is a leading cause of human morbidity and mortality that
often targets epithelial surfaces. Host immunocompromise, or the presence of indwelling
medical devices, including contact lenses, can predispose to infection. While medical
devices are known to accumulate bacterial biofilms, it is not well understood why
resistant epithelial surfaces become susceptible to P. aeruginosa. Many bacteria,
including P. aeruginosa, release outer membrane vesicles (OMVs) in response to stress
that can fuse with host cells to alter their function. Here, we tested the hypothesis
that mucosal fluid can trigger OMV release to compromise an epithelial barrier. This
was tested using tear fluid and corneal epithelial cells in vitro and in vivo. After 1 h
both human tear fluid, and the tear component lysozyme, greatly enhanced OMV
release from P. aeruginosa strain PAO1 compared to phosphate buffered saline (PBS)
controls (∼100-fold). Transmission electron microscopy (TEM) and SDS-PAGE showed
tear fluid and lysozyme-induced OMVs were similar in size and protein composition, but
differed from biofilm-harvested OMVs, the latter smaller with fewer proteins. Lysozymeinduced OMVs were cytotoxic to human corneal epithelial cells in vitro and murine
corneal epithelium in vivo. OMV exposure in vivo enhanced Ly6G/C expression at the
corneal surface, suggesting myeloid cell recruitment, and primed the cornea for bacterial
adhesion (∼4-fold, P < 0.01). Sonication disrupted OMVs retained cytotoxic activity, but
did not promote adhesion, suggesting the latter required OMV-mediated events beyond
cell killing. These data suggest that mucosal fluid induced P. aeruginosa OMVs could
contribute to loss of epithelial barrier function during medical device-related infections.
Keywords: Pseudomonas aeruginosa, outer membrane vesicles, human tears, lysozyme, cornea, epithelium,
adhesion, microbial keratitis

INTRODUCTION
Contact lenses are among the indwelling medical devices that can promote bacterial-induced
pathology. In addition to sight-threatening corneal infection, microbial contamination of
lenses and lens cases can cause various potentially serious and/or painful inflammatory
events including contact lens-related acute red eye (CLARE), contact lens-induced peripheral
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of P. aeruginosa biofilms (Schooling and Beveridge, 2006;
Toyofuku et al., 2012), and are known to mediate bacterial
co-aggregation to enable biofilm formation and colonization
of receptive surfaces in P. aeruginosa (Beveridge et al., 1997;
Schooling and Beveridge, 2006; Schooling et al., 2009) as well as
other Gram-negative bacteria (Yonezawa et al., 2009).
Since biofilms can form on contact lenses in vivo (Tam
et al., 2010) and in contact lens storage cases (Stapleton and
Dart, 1995), and antimicrobials and other potential stressors
can be present in either location, P. aeruginosa-derived OMVs
could be relevant to the pathogenesis of contact lenses-related
adverse events. Here, we tested the hypothesis that human
tear fluid, its abundant antimicrobial constituents lysozyme and
lactoferrin, or lysates of human corneal epithelial cells induce
OMV production. We also explored if P. aeruginosa-derived
OMVs could compromise corneal epithelial barrier function.

ulcer (CLPU), and infiltrative keratitis (IK) (Stapleton et al., 2009;
Willcox et al., 2011; Nagaraju et al., 2014).
Pseudomonas aeruginosa has been the most common cause
of contact lens-related corneal infection since soft contact lenses
were introduced in the early 1970’s (Stapleton and Carnt, 2012).
Why the normally resistant cornea becomes susceptible to this
pathogen during lens wear is not well understood (Evans and
Fleiszig, 2013; Mantelli et al., 2013). In the absence of lens wear,
overcoming barrier function to P. aeruginosa requires significant
compromise; e.g., superficial injury using tissue paper followed by
ethylene glycol tetra-acetic acid (EGTA) treatment or profound
innate immune deficiency (Mun et al., 2009; Alarcon et al., 2011;
Augustin et al., 2011; Tam et al., 2011; Sullivan et al., 2015). Yet we
have shown that the same bacteria can reliably infect the cornea
in a (rat) lens-wearing model if given sufficient time, even if very
small inocula are used (Tam et al., 2010). Since lenses removed
from infected eyes caused disease faster than lenses inoculated
in vitro, the data suggested that bacteria launched additional
virulence factors when adapted to the eye-lens environment.
Under various growth conditions, P. aeruginosa and other
Gram-negative bacteria, can release vesicles from their outer
membrane (outer membrane vesicles, OMVs; Kadurugamuwa
and Beveridge, 1995). OMVs can elicit a wide array of functions
that can potentially influence bacterial survival and pathogenesis.
For example, they are involved in bacterial responses to envelope
or oxidative stress (Macdonald and Kuehn, 2013), competition in
microbial communities (Kadurugamuwa and Beveridge, 1996),
horizontal gene transfer (Rumbo et al., 2011) and host-pathogen
interactions. OMVs can be found in clinical specimens from
infected subjects and they can mediate immune suppression or
immune stimulation (Namork and Brandtzaeg, 2002; Bauman
and Kuehn, 2006; Tan et al., 2007). The mechanism by which
OMVs exert these effects can involve delivery of their contents
across anatomical barriers by fusion with host cell membranes
(Kadurugamuwa and Beveridge, 1998), providing the potential
to modulate numerous host cell functions (Yu and Kim, 2012).
While the Gram-negative Treponema denticola OMVs have been
shown to disrupt barrier function of cell monolayers in culture
(Chi et al., 2003), whether OMVs can disrupt barrier function
in vivo has not been explored for any bacteria.
Outer membrane vesicles shedding is a tightly regulated
process, with different environmental stimuli or bacterial
lifestyles able to produce different types of OMV in both
appearance and content (Kadurugamuwa and Beveridge, 1995;
Schooling and Beveridge, 2006; Maredia et al., 2012; Toyofuku
et al., 2012; Park et al., 2014). In particular, bacteria can produce
OMVs in response to stresses such as temperature (Katsui et al.,
1982), oxidative stress (Thompson et al., 1985), and antibiotics
(Kadurugamuwa and Beveridge, 1995), through activation of the
SOS response (Maredia et al., 2012).
Known P. aeruginosa OMV contents include proteases
involved in basement membrane traversal by P. aeruginosa
(Alarcon et al., 2009), and Cif [Cystic Fibrosis Transmembraneconductance Regulator (CFTR) Inhibitory Factor] toxin
(Bomberger et al., 2009) which can remove CFTR from the
membrane of host cells and target it for degradation (Bomberger
et al., 2009, 2011). OMVs also represent an intrinsic component
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MATERIALS AND METHODS
Human Tear Fluid
Human tears were collected from healthy human volunteers
using a 30 µl-volume capillary tube under a protocol approved by
the Committee for the Protection of Human Subjects, University
of California, Berkeley. Subjects were non-contact lens wearers,
both males and females, between 18 and 45 years of age and with
no ocular infection or inflammation at the time of collection.
Approximately 5% of the tear fluid from each subject was
plated on TSA plates (see methods) to control for bacterial
contamination; sterile tear fluid was pooled (from 6 to 8 subjects)
and stored at −80◦ C until used.

Reagents
Contrived artificial tears were purchased from Ursa BioScience
(Bel Air, MD). The complete list of tear components, and
their concentration, in the contrived artificial tears remains
proprietary. However, the components disclosed by the
manufacturer include immunoglobulins (γ-globulins), albumin
(human), lysozyme and salts, with an osmolarity of 300 mOsm,
and pH 7.4. Lactoferrin (from human milk), recombinant
human lysozyme, and other reagents were purchased from
Sigma–Aldrich (St. Louis, MO, USA).

Cell Culture and Cell Lysates
Human telomerase immortalized corneal epithelial cells (hTCEpi;
Robertson et al., 2005) were maintained at 37◦ C in 5% CO2
in keratinocyte growth medium (KGM-2) containing 0.15 mM
CaCl2 (Lonza, Walkersville, MD, USA). Cells were grown as
monolayers or multilayers on either 96-well tissue culture plates
or airlifted on collagen-coated Transwell filters in 12-well tissue
culture plates, for use in cytotoxicity and traversal experiments,
respectively (see methods below). To prepare lysates from
hTCEpi cells for treatment of bacteria, hTCEpi cells were grown
on 6-well tissue culture plates until confluent, then lysed by
repeated cycles of cell freezing and thawing in phosphate buffered
saline (PBS) followed by centrifugation (12,000 × g, 10 min,
4◦ C) to remove insoluble material. The supernatant (lysate) was
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of protein, or normalized according the number of bacteria used
for OMV preparation (∼1011 CFU/mL). Samples were mixed
with Laemmli buffer (Bio-Rad, Hercules, CA, USA), subject to
electrophoresis using 4–15% Mini-Protean TGX Gels (Bio-Rad)
and visualized with Coomassie blue or silver stain (Bio-Rad). In
some experiments, lysozyme-induced OMVs were sonicated (6
cycles of 30 s each with 30 s pause at maximum power) on ice
and/or proteinase K treated (5 µg/mL, 30 min, 37◦ C) to cause
membrane disruption which was confirmed using SDS-PAGE
stained with Coomassie blue.

assessed for protein concentration [Bicinchoninic Acid (BCA)
Assay Kit, Pierce Biotechnology Inc., Thermo Scientific] and
exposed to P. aeruginosa at 0.5 or 1.0 mg/mL of total protein as
outlined below.

Bacterial Strains and OMV Preparation
Pseudomonas aeruginosa strains used were; PAO1, PA14 and
19660 (laboratory strains) and PAK, 6206 and 6294 (clinical
isolates). For fluorescent imaging PAO1 was transformed with
plasmid pSMC2 encoding green fluorescent protein (PAO1-GFP;
Bloemberg et al., 1997) or d-Tomato fluorescent protein (Singer
et al., 2010). Bacteria were grown on TSA plates for 24 h at
37◦ C except for plasmid-complemented bacteria for which TSA
was supplemented with carbenicillin 400 µg/mL. For use in
experiments, bacteria were resuspended into either PBS to a
concentration of ∼1011 CFU/mL for OMV preparation, or in
KGM-2 (without antibiotics) to ∼1011 CFU/mL then diluted as
needed for use in ex vivo bacterial association, cytotoxicity or
traversal experiments.
For preparation of OMVs from agar plate grown bacteria,
a modified version of the protocol reported by Schooling and
Beveridge (2006) was used. Briefly, P. aeruginosa strains were
grown on 2 × 10 cm TSA plates for 24 h at 37◦ C to form a
“lawn” covering. Bacteria were scraped from the agar surface and
resuspended in 10 mL of PBS to form a homogeneous suspension
of ∼1010 CFU/mL. Bacteria were then removed by centrifugation
(12,000 × g, 20 min, 4◦ C) three times. Supernatants were then
pooled, centrifuged (12,000 × g, 20 min, 4◦ C) and filtered (0.45
and 0.22 µm pore size) to remove remaining bacteria and large
aggregates, and subjected to ultracentrifugation (150,000 × g, 3 h,
4◦ C). The pellet containing OMVs was then resuspended in PBS,
and subjected to low speed centrifugation (16,000 × g for 30 min,
4◦ C) to clear most contaminating flagella (Renelli et al., 2004;
Schooling and Beveridge, 2006). The resulting preparations were
considered TSA-grown OMVs.
For induction of OMVs, PAO1 was treated with human tear
fluid, contrived artificial tears, lysozyme, lactoferrin, or corneal
epithelial cell lysates. Firstly, bacteria were grown overnight
on TSA plates (as above), and then resuspended in 10 mL of
PBS. After washing once to remove previously formed OMVs,
bacteria were resuspended in 1 mL of PBS to a concentration
of ∼1011 CFU/mL and incubated for 1 h at 37◦ C (uninduced
OMVs). Otherwise, bacteria were resuspended in 1 mL of either
human tear fluid (pooled from 6 to 8 subjects), lysozyme in PBS
(1.5 mg/mL, 102 µM), lactoferrin in PBS (1 mg/mL, 13 µM), or
corneal epithelial cell lysates (preparation described above), for
1 h at 37◦ C and compared with PBS (uninduced) controls. OMVs
were then prepared as described above after dilution to 10 mL
of PBS. The OMV preparations were quantified for total lipid
content in triplicate using a fluorescent lipophilic dye FM1-43FX
(Thermo Fisher Scientific; Frias et al., 2010; Murphy et al., 2014)
according to manufacturer instructions. Relative fluorescence
units (RFU)/mL was divided by optical density at 600nm (OD600 )
of the bacteria at the time of vesicle harvest to generate the OMV
yield (RFU/OD600 ). The OMV preparations were also quantified
for total protein content (BCA Assay Kit, Pierce). For SDS-PAGE,
samples were either standardized to contain equivalent amounts
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Transmission Electron Microscopy
Samples were assessed by negative staining as described by
Schooling and Beveridge (2006), and examined using an FEI
Tecnai 12 Transmission electron microscope operating at
an acceleration voltage of 100 kV under standard operating
condition.

Assays for OMV Cytotoxicity and
Bacterial Traversal
For cytotoxicity assays in vitro, hTCEpi cells in antibioticfree KGM-2 media were grown to 90% confluence in 96well tissue culture–treated plates and then incubated with
intact lysozyme-induced OMVs, sonicated OMVs or uninduced
(basal) OMVs for 1, 2, and 4 h. Each OMV sample was
inoculated at a concentration corresponding to the approximate
amount produced by ∼109 CFU of P. aeruginosa. Cytotoxicity
was calculated by measuring LDH release in the supernatant
using a cytotoxicity detection kit (Roche, Indianapolis, IN,
USA). In each experiment, percent cytotoxicity was calculated
relative to PBS buffer as a negative control (0% cytotoxicity)
and Triton X-100 (1% vol/vol) treated as a positive control
(100% cytotoxicity). To asses cytotoxicity of OMVs in murine
corneas, mice were anesthetized with intraperitoneal injection
of ketamine (90 mg/kg) and dexmedetomidine (0.5 mg/kg;
Hahn et al., 2005), then inoculated once with 5 µl of purified
intact lysozyme-induced OMVs, sonicated lysozyme-induced
OMVs, or PBS buffer, then incubated for 4 h. Anesthesia
was maintained throughout the 4 h exposure period. OMV
preparations were both at a concentration of ∼1 mg/mL of total
proteins, corresponding to the approximate amount produced by
∼109 CFU of P. aeruginosa strain PAO1, a typical inoculum size
(in 5 µl) for studies of P. aeruginosa interactions with the murine
cornea in vivo or ex vivo (Alarcon et al., 2011; Tam et al., 2011;
Sullivan et al., 2015). After euthanasia, freshly enucleated eyes
were washed three times in PBS prior to incubation with NucBlue
(all cell nuclei) and NucGreen (permeabilized cell nuclei; Thermo
Fischer) in DMEM (Gibco) at room temperature for 30 min.
After rinsing, eyes were glued on coverslip, soaked in DMEM and
imaged by confocal microscopy using reflection 635 nm (corneal
cells), 405 nm (NucBlue) and 488 nm (NucGreen) lasers. Z stacks
(2.0 µm steps) were collected from 4 or more eyes per treatment.
Image analysis was performed with Image-J.
For in vitro bacterial traversal assays, polarized multilayers
of hTCEpi cells were generated by seeding 5 × 104 cells/mL
onto 12-well collagen-coated tissue culture inserts (3 µm
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Dulbecco’s Modified Eagle’s Medium (DMEM) and imaged by
confocal microscopy with unpreserved eye drop as an interface
with the objective lens, using reflection 635 nm (corneal cells),
559 nm (PAO1-dTomato) 488 nm (PAO1-GFP or NucGreen)
and 405 (NucBlue/DAPI) lasers. Z stacks (1.0 µm steps)
were collected from 4 or more random fields per sample. 3D image reconstruction was performed by Image-J. Bacterial
adherence was defined as the total area (µm2 ) occupied by
the GFP or dTomato signal on the corneal surface for each
field.

pore size; Corning, Inc., NY) in KGM-2 medium containing
1.15 mM CaCl2 (high calcium) and airlifting for 7 days as
previously described (Robertson et al., 2005). Cells where then
pre-incubated in the apical compartment for 1 h with intact
(lysozyme-induced) OMVs, sonicated lysozyme-induced OMVs,
uninduced (basal) OMVs or PBS buffer in 5% CO2 at 37◦ C.
As with other assays, each OMV sample was inoculated at
a concentration corresponding to the approximate amount
produced by ∼109 CFU of P. aeruginosa. After washing, PAO1
inocula (106 CFU per well) in KGM-2 without antibiotics were
carefully added to the apical compartment, and incubated with
the cells (5% CO2 at 37◦ C) for 4 h. Traversed bacteria were then
quantified by viable counts of the basal compartment.

Statistical Analysis
In vitro data were expressed as a mean ± standard deviation (SD).
Statistical analysis of differences between groups was determined
using Student’s t-Test or ANOVA with Tukey’s post hoc analysis.
For ex vivo experiments, data were expressed as a median
with upper and lower quartiles, and differences between groups
determined with ANOVA with Tukey’s post hoc analysis, or
the Mann Whitney U test or Kruskal–Wallis test for two or
three groups, respectively. P-values of < 0.05 were considered
significant. All experiments were performed at least three times
unless otherwise stated.

Cornea Whole Mount and
Immunostaining
Eyes from C57BL/6 mice (male and female, 6–12 weeks of
age) were used. The use of animals was approved by the
Animal Care and Use Committee of the University of California,
Berkeley. Following euthanasia, eyes were enucleated and fixed
in 2% paraformaldehyde (PFA) for 15 min. The corneas were
excised and further incubated in 2% PFA for an additional
45 min, washed and blocked in PBS/2% BSA for 30 min and
permeabilized in PBS/2% BSA/0.1% TritonX-100 for 30 min at
room temperature. Anti-Ly6G/C (NIMP-R14, Rat IgG2b, 1:50
Thermo Fisher) antibodies were prepared in the permeabilizing
solution and incubated with the mouse corneas overnight at 4◦ C.
The corneas were then washed with PBS, incubated with 488Dylight anti-rat secondary antibody (Thermo Fisher) for 3 h at
room temperature, and counterstained with DAPI. The whole
mount corneas were cover slipped and visualized using confocal
microscope as described above. As a control, some samples were
processed without primary antibody to control for non-specific
binding of secondary antibody, or using an isotype control (Rat
IgG2b, 1:50 Thermo Fisher).

RESULTS
P. aeruginosa Strains Able to Infect the
Cornea Differ in OMV Quantity and
Composition
First, we explored the OMV forming capacity of six P. aeruginosa
strains able to cause corneal infections in mice (Preston et al.,
1995). They included three laboratory strains (PAO1, 19660,
and PA14) and three clinical isolates from human infections
(6206 and 6294, from corneal infections and strain PAK from
bacteremia). To trigger OMV production, extended growth
(24 h) on Trypticase Soy Agar (TSA) at 37◦ C was used (Schooling
and Beveridge, 2006). While all strains produced OMVs, there
was considerable variability in protein and lipid content for
each (Figures 1A,D). For example, strain 6206 released more
OMVs than strain PAO1 (2.82 vs. only 0.63 µg/OD600 of protein
content, or 1729.67 vs. 494.33 RFU/OD600 of lipid content;
Figures 1B,D). Greater amounts of high molecular weight bands
at the top of lanes, e.g., PAO1 and PA14 (Figure 1A), suggested
differences in OMV aggregation capabilities between strains.
There were also differences in the appearance of OMV pellets
after ultracentrifugation (Figure 1C). PAO1, PA14, and 6294
(lanes 1, 2, and 5) yielded a bigger, yellow, gelatinous pellet;
while OMV pellets from PAK, 6206, 19660 (lanes 3, 4, and
6) were clear. These two phenotypes were reported previously
when comparing OMV pellets from planktonically-grown PAO1
(clear) to those from biofilm grown PAO1 (bigger, brown
and gelatinous; Schooling and Beveridge, 2006). Differences in
pellet appearance did not seem to correlate with differences
in protein banding patterns; a dominant band was observed
in strains 6294 and 19660 (Figure 1A), which had gelatinous
and clear pellets, respectively (Figure 1C), although the clear

Bacterial Association with Murine
Corneal Epithelium Ex Vivo
3D quantitative confocal imaging ex vivo was used as previously
described (Tam et al., 2011) with some minor modifications.
Briefly, enucleated eyeballs of C57BL/6 wild-type mice were
rinsed with PBS, untreated or blotted with tissue paper
on the corneal surface to enable susceptibility to bacterial
adhesion (Alarcon et al., 2011), and pre-incubated for 1 h
with the following: purified intact lysozyme-induced OMVs,
sonicated lysozyme-induced OMVs, uninduced (basal) OMVs
or PBS buffer. Preparations were standardized according to the
number of bacteria used to generate the OMV preparations
(∼1011 CFU/mL). In other experiments, non-blotted eyes were
inoculated in vivo with purified intact lysozyme-induced OMVs,
sonicated lysozyme-induced OMVs or PBS buffer for 4 h under
anesthesia prior to sacrificing the mice and enucleating the eyes as
described above (see Assays for OMV cytotoxicity and traversal).
Eyeballs were then incubated at 37◦ C in ∼1011 CFU/mL of
P. aeruginosa PAO1-GFP for 5 h. After rinsing to remove nonadherent bacteria, eyes were placed on cotton wool soaked in
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FIGURE 1 | (A) SDS-PAGE of outer membrane vesicles (OMVs) purified from six different Pseudomonas aeruginosa strains showing relative differences in protein
composition after 24 h growth on TSA at 37◦ C (TSA-grown OMVs). Samples were standardized to contain equal amounts of protein (∼10 µg). ∗ High molecular
weight bands at the top of lanes. # Dominant band from pellets of 6294 and 19660 also found in PAO1 and PA14 (B) OMV preparations from strains 6206 and
PAO1 grown as above, but normalized for bacterial numbers (see Materials and Methods). Under these growth conditions, strain 6206 showed greater OMV
production (0.9 vs. 0.2 mg/mL of total protein). (C) Photographs of OMV pellets from different P. aeruginosa strains after ultracentrifugation and before resuspension
with PBS show differences in OMV pellets between lanes 1, 2, and 5 (brown, gelatinous) vs. 3, 4, and 6 (clear). (D) Quantification of total protein content (µg/OD600 )
and lipid content (Relative Fluorescent Units, RFU/OD600 ) normalized to bacterial OD, for the six different P. aeruginosa isolates.
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into OMV preparations after purification (Figure 3A, lane 6).
However, some components of contrived artificial tears were
retained after OMV purification (Figure 3A, lane 7). As expected,
based on published literature (Cowell et al., 1997; Callewaert
et al., 2008; Kamiya et al., 2012), neither human tear fluid,
nor lysozyme, affected viability of P. aeruginosa strain PAO1
(measured by CFU viable counts before and after 1 h incubation)
compared to untreated controls (data not shown). While artificial
tears caused a small decrease in bacterial viability, it was not
significantly different to untreated controls (p = 0.075, Student’s
t-test).
Transmission electron microscopy (TEM) was used to assess
morphological aspects of OMVs after the various induction
methods. Representative micrographs are shown in Figure 3B.
While the uninduced (PBS) control samples contained only
a small number of OMVs, numerous OMVs were released
after 24 h growth on TSA plates (TSA-grown OMVs), or
1 h treatment with either human tear fluid (induced OMVs)
contrived artificial tears, or lysozyme. Qualitatively, OMVs
induced by tear fluid or lysozyme appeared larger and more
homogeneous than TSA-grown OMVs. There was also evidence
of residual flagella contamination of OMV preparations, despite
efforts to remove it with low-speed centrifugation, and this
may contribute to protein banding patterns seen in Figure 3A.
Differences observed in SDS-PAGE OMV banding patterns
(Figure 3A) and morphology (Figure 3B) suggested that
tear fluid or lysozyme may induce different OMVs from
P. aeruginosa compared to bacteria grown for 24 h on TSA.
However, further studies are needed to fully investigate this
finding.

OMV pellets of 6206, PAK, 19660 showed more bands of higher
MW (Figure 1A). There were also no obvious correlations of
the two groups with previously described differences among
these strains, e.g., ocular isolates, LPS serogroup, or cytotoxic
versus invasive phenotypes. For the remainder of the study we
used PAO1 because of the extensive genotypic and phenotypic
characterization of this strain in the literature compared to the
other strains.

Human Tear Fluid and Lysozyme Induce
OMV Release by PAO1
Under a contact lens, bacteria are exposed to the posterior surface
of the lens, epithelial cells at the anterior surface of the cornea
on which the lens sits, and tear fluid trapped between these two
surfaces. Given the presence of antimicrobial factors associated
with corneal epithelial cells and tear fluid, we tested both for
their capacity to trigger OMV production by P. aeruginosa strain
PAO1.
When the bacteria were exposed to cell lysates of cultured
human corneal epithelial cells for 1 h (Cell lysate-induced),
OMV release was similar to the baseline control (Uninduced)
PBS exposure (Figure 2A). Transmission electron microscopy
(TEM) micrographs confirmed that few or no OMVs were
present in either the uninduced PBS or induced cell lysate
bacterial samples (Figure 2B). The nature of the small round
particles observed in the induced cell lysate samples (Figure 2B)
was not clear; morphological appearance and protein banding
pattern suggested they were not bacterial OMVs, but instead
likely to be vesicles or debris derived from the epithelial
cells.
Next, bacteria were exposed to undiluted tear fluid collected
from human volunteers or commercially available artificial
human tear fluid for 1 h, which both triggered a large
increase in OMV production compared to uninduced control
as shown in Figure 3A, lane 2 vs. lanes 4 and 5 (∼100-fold
increase as measured by total protein content, ∼60-fold increase
as measured by total lipid content). To explore which tear
components triggered OMVs we tested purified lactoferrin and
lysozyme, selected because of their abundance in human tear fluid
and artificial tears, their known antimicrobial activity (Selinger
et al., 1979; Flanagan and Willcox, 2009), and because both
can deposit on the posterior surface of contact lenses (Hall
et al., 2014). Lysozyme, but not lactoferrin, triggered OMV
release, and lysozyme-triggered OMVs had a similar proteinbanding pattern to those induced by human tear fluid and
contrived artificial tears (Figure 3A, lanes 3–5) and different
protein banding patterns than OMVs extracted after growth on
TSA for 24 h (Figure 3A, lane 1 vs. lanes 3–5). In this Figure,
OMV preparations were normalized for bacterial numbers to
show the impact of TSA growth versus tear fluid (or tear
components) on the same number of bacteria. As such protein
concentrations varied between OMV samples. However, the
protein concentration of TSA-grown OMVs (0.86 µg/µl) was
quite similar to lysozyme-induced OMVs (1 µg/µl) allowing a
comparison of lanes 1 and 3 from that perspective. Controls
without bacteria confirmed the absence of lysozyme carryover
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Lysozyme-Induced PAO1 OMVs Are
Cytotoxic to Human Corneal Epithelial
Cells In Vitro
To explore the impact of OMVs on corneal epithelial cells,
lysozyme was used rather than human tear fluid or artificial
tears due to; (1) the ready availability and consistency of purified
human lysozyme compared to native human tears, (2) the
similarity of OMVs obtained using lysozyme (Figures 3A,B),
and (3) the absence of lysozyme (or other contaminant) carryover from the OMV preparation protocol (Figure 3A, lane 6)
compared to artificial tears (Figure 3A, lane 7). To distinguish
between impact of intact OMVs and their contents, a portion of
lysozyme-induced OMV preparations were sonicated to disrupt
membrane integrity before each assay. Membrane disruption
after sonication was verified using proteinase K digestion and
TEM (Figures 4A,B).
To ensure relevance to humans, we first used cultured
telomerase immortalized human corneal epithelial cells to
examine the cytotoxic capacity of OMVs. Cells were grown as
monolayers to ensure that the apical side of every cell in the
culture would be exposed to OMVs. Cytotoxicity was quantified
using LDH release assays. As shown in Figure 5A, lysozymeinduced OMVs were ∼3-fold more cytotoxic toward cultured
human corneal epithelial cells than uninduced preparation,
with greater than 50% cytotoxicity after 4 h of exposure. No
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FIGURE 2 | (A) SDS-PAGE silver-stained gel showing OMV preparations after 1 h incubation in PBS buffer (uninduced, lane 1) and corneal epithelial cell lysate
induced (lanes 2 and 3). OMV preparations were normalized for bacterial numbers (B) TEM micrographs of the OMV preparations. Scale bar = 200 nm.
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FIGURE 3 | (A) SDS-PAGE (silver-stain) gels showing OMV preparations from P. aeruginosa strain PAO1 after 24 h growth on TSA (TSA-grown), 1 h incubation in
PBS (uninduced), lysozyme (1.5 mg/mL), contrived artificial tear fluid, or human tear fluid. As controls, lysozyme or contrived artificial tears without bacteria were
subject to OMV purification. Lysozyme did not carryover into OMV preparations after purification (lane 6). However, some components of contrived tears survived the
OMV purification process (lane 7). TSA-grown indicates OMV extracted after 24 h growth on TSA. OMV preparations were normalized for bacterial numbers.
However, protein concentration of TSA-grown OMVs (0.86 µg/µl) was similar to lysozyme-induced OMVs (1 µg/µl) allowing comparison of lanes 1 and 3 from that
perspective. (B) TEM micrographs of OMVs, after 24 h growth on TSA (TSA-grown), 1 h treatment with PBS (uninduced), contrived artificial tear fluid, lysozyme and
human tear fluid. Differences in OMV size and relative quantity were clearly evident along with some residual flagella contamination that may contribute to protein
banding in (A). Scale bar = 200 nm.
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Lysozyme-Induced OMV Pretreatment
for 1 h Does Not Promote Susceptibility
to P. aeruginosa Traversal for
Multilayered Human Corneal Epithelial
Cells Grown In Vitro
Multilayers of human corneal epithelial cells were then used
to determine if lysozyme-induced OMVs had any impact on
epithelial barrier function to P. aeruginosa at a time when OMVs
were not yet cytotoxic to the cells (i.e., 1 h). Cells were grown on
Transwell filters (3 µm pore-size) and subsequently airlifted for
7 days to encourage stratification before pre-treatment with PBS,
uninduced preparation, or lysozyme-induced OMVs (intact or
sonicated) for 1 h. After washing, ∼106 CFU P. aeruginosa PAO1
were added to the apical cell surface (apical compartment) for
4 h before viable counting both the apical and basal chambers to
enumerate survivors at the inoculation surface and those that had
traversed the cells. The results revealed no significant difference
in the number of bacteria that traverse the cells after the 1 h
pretreatment with OMVs (Figure 5B, gray bars). Intriguingly,
fewer bacteria were recovered from the apical (inoculation)
compartment for lysozyme-induced OMVs by the end of the
assay (Figure 5B, black bars), which might have masked increases
in susceptibility to bacterial traversal for those samples.

Lysozyme-Induced PAO1 OMVs Are
Cytotoxic to Host Cells in the Mouse
Cornea In Vivo and Promote Recruitment
of Ly6G/C Positive Cells
Mice were used to study the cytotoxicity of OMVs in vivo,
utilizing NucGreen to visualize permeabilized corneal cells. As
shown in Figure 6A, after 4 h in vivo treatment with lysozymeinduced OMVs, there was a consistent increase in the number
of dead cells (green) compared to PBS inoculated corneas
(quantified in Figure 6C). Consistent with the in vitro human
cell data, we observed no differences in the number of dead
cells for mouse corneas treated with intact and sonicated OMV
preparations. Surprisingly, for both intact and sonicated OMV
treated corneas we also observed a general increase in the number
of nuclei positive for NucBlue (DAPI), a dye that labels all
nuclei irrespective of their membrane permeability (Figure 6B).
Likely contributing to this increase in cell number at the corneal
surface, some cells in OMV treated corneas had irregular nuclei
suggesting that they were myeloid cells, not epithelial cells
(enlarged panels in Figure 6A, merge). Labeling of wholemount mouse corneas for the cell marker Ly6G/C supported
the hypothesis that these were myeloid cells recruited as a result
of OMV challenge (Figure 7A, quantified in Figure 7B), the
use of isotype and secondary-only antibody controls confirmed
labelling specificity (Figure 7C).

FIGURE 4 | (A) SDS-PAGE with Coomassie stain showing P. aeruginosa
PAO1 OMV preparations induced by purified human lysozyme (1.5 mg/mL) for
1 h with and without sonication or proteinase K treatment. Untreated
lysozyme-induced OMVs (lane 1), sonicated lysozyme-induced OMVs (lane 2),
proteinase K treated lysozyme-induced OMVs (lane 3), sonicated and
proteinase K treated lysozyme-induced OMVs (lane 4). Comparison of the
latter with lanes 1–3 indicated several proteins (asterisks) that became more
susceptible to proteinase K digestion suggesting the disruption of OMV
membrane integrity. Samples were standardized to contain equal amounts of
protein (∼10 µg). (B) TEM micrograph of sonicated lysozyme-induced OMVs
(Sonicated Lys-OMV) showing semi-disrupted vesicles (arrows). Scale
bar = 200 nm.

Lysozyme-Induced OMVs Promote
P. aeruginosa Association with the
Murine Corneal Epithelium Ex Vivo

cytotoxicity was observed after 1 h, and differences were not yet
significant at 2 h. Sonicated OMVs killed a similar percentage of
cells as intact OMVs, showing that OMV membrane integrity
was not required for the cytotoxic effects of lysozyme-induced
OMVs.
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Given the cytotoxic impact of lysozyme-induced P. aeruginosa
OMVs on mouse corneas, we explored their effect on
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FIGURE 5 | (A) Cytotoxicity of uninduced or lysozyme-induced OMVs (Lys-OMV) toward human corneal epithelial cells measured by LDH release. Percent
cytotoxicity expressed relative to PBS buffer and Triton X-100 (1% vol./vol.) as negative and positive controls, respectively. (B) Effects of OMV pre-treatment on
P. aeruginosa traversal of multilayered human corneal epithelial cells in vitro. After 1 h pre-incubation with PBS or different OMV preparations, airlifted cell multilayers
were challenged with ∼106 CFU of P. aeruginosa PAO1 for 4 h (5% CO2 , 37◦ C). Bacteria were recovered and counted from the apical compartment (upper
chamber, black bars, left Y -axis) and basal compartment (traversed, gray bars, right Y -axis). Significantly fewer bacteria were recovered from the apical (inoculation)
compartment for lysozyme-induced OMVs (Lys-OMV) by the end of the assay; lysozyme-induced OMVs (intact or sonicated) had no impact on traversal. Data are
expressed as the mean ± SD from three independent experiments. ∗ P < 0.002 compared to PBS, ∗∗ P = 0.0017, ∗∗∗ P = 0.0002 (Two-way ANOVA with Tukey’s
multiple comparison test).

some corneas were blotted with tissue paper (KimwipeTM ).
As described in our previous publication, this blotting
process disrupts corneal epithelial barrier function against
the small molecule fluorescein and increases susceptibility to

P. aeruginosa interactions with the mouse corneal epithelium.
One eye of mice was pretreated with one of the various OMV
preparations, followed by incubation with ∼1011 CFU/ml
P. aeruginosa PAO1-GFP for 5 h. Before OMVs were added,
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FIGURE 6 | (A) Cytotoxicity in murine corneas after 4 h in vivo treatment with PBS, lysozyme-induced OMVs (Lys-OMV) and sonicated lysozyme-induced OMVs
(1 mg/ml of total proteins). Whole eyes where enucleated and incubated with NucBlue (all nuclei) and NucGreen (nuclei of permeabilized cells) for 30 min prior to
imaging. Maximum intensity projection of blue channel (all nuclei), green channel (dead cells) and merge from a representative experiment are shown for each
condition. (B,C) Quantification of total cells and dead cells from four mice per group across four independent experiments. Data are expressed as a median with
upper and lower quartiles. ∗∗ P < 0.01, ∗∗∗ P < 0.001, ∗∗∗∗ P < 0.0001 (One-way ANOVA with Tukey’s multiple comparison test).
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FIGURE 7 | (A) Ly6G/C flat mount immune staining showing an increase in the number of cells expressing the myeloid marker Ly6G/C after a 4 h in vivo inoculation
with lysozyme-induced OMVs (Lys-OMV) or PBS as a control. (B) Quantification of the Ly6G/C positive signal (green) in µm2 from five mice per group across three
independent experiments. (C) Controls showing the absence of Ly6G/C labeling in OMV treated samples (4 h) after using an isotype antibody (Rat IgG2b) or a
secondary antibody only. Data expressed as a median with upper and lower quartiles. ∗∗ P < 0.008 (Mann–Whitney U test).

P. aeruginosa adhesion (Tam et al., 2011). Eyeballs were imaged
ex vivo using our published 3D quantitative confocal imaging
methods (Tam et al., 2011), using an unpreserved eye drop
between the objective and cornea to keep the surface moist
(Figure 8A).
The results showed that even for previously healthy (nonblotted) corneas, there was a significant (∼4-fold) increase in
the number of bacteria adhering to the corneal epithelium
if the inoculum was added after corneal pre-treatment with
intact lysozyme-induced OMVs for 4 h (Figures 8B,C).
This increase was significant compared to both PBS and
disrupted OMVs (P < 0.004 and P < 0.03, respectively).
If corneas were superficially injured (blotted), only 1 h of
OMV pretreatment was needed to promote a significant
increase in bacterial adhesion (Figures 9A,C; Supplementary
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Figures S2A–C). However, 1 h OMV pretreatment of a
healthy cornea (non-blotted) was insufficient to promote
increased adhesion, even if the experiment was done ex vivo
(Figure 9B). Thus, superficial injury rendered the corneas
even more susceptible to OMV priming for P. aeruginosa
adhesion.
For both blotted and non-blotted corneas, the adhesion
promoting effect of OMVs required that OMVs were intact.
Pre-exposure to sonicated OMVs produced effectively the same
results as pre-exposure to control PBS (Figures 8B,C and 9A,C;
Supplementary Figures S2A–C) and uninduced OMVs (data not
shown). While bacteria were bound to the epithelial surface in
response to OMV priming, they did not appear to penetrate
into deeper layers of the epithelium under any of the conditions
examined.
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FIGURE 8 | (A) Schematic representation of the experimental set up for imaging murine corneas ex vivo. (B) Confocal images of non-blotted murine corneas after
4 h in vivo pre-treatment with different OMV preparations or PBS control followed by 5 h ex vivo incubation of the enucleated eyes with ∼1011 CFU/ml P. aeruginosa
PAO1-GFP. Representative 3D reconstructed images show greatly increased bacterial association with corneas treated with lysozyme-induced OMVs (second
panel), which was significantly attenuated if the same OMVs were sonicated prior to pretreatment (third panel). (C) Quantification of P. aeruginosa associated with
murine corneas under each condition. Data from four mice per group across four independent experiments are expressed as a median with upper and lower
quartiles. ∗ P < 0.03, ∗∗ P < 0.004 (One-way ANOVA with Tukey’s multiple comparison test).

Given the known contribution of OMVs to initiation of
biofilms (Schooling and Beveridge, 2006; Schooling et al., 2009;
Yonezawa et al., 2009) we also examined bacterial aggregates
on the corneal epithelium (after 1 h OMV pre-treatment of
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blotted corneas). The average size and size distribution of
P. aeruginosa aggregates on the murine corneal surface in each
field was analyzed using Image J. No significant differences in
P. aeruginosa aggregate size were observed when comparing
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FIGURE 9 | (A) Confocal images of murine corneas ex vivo after tissue-paper blotting and 1 h pre-treatment with different OMV preparations or PBS control followed
by 5 h incubation with ∼1011 CFU/ml P. aeruginosa PAO1-GFP. Representative 3D reconstructed images show greatly increased bacterial association with blotted
corneas also treated with lysozyme-induced OMVs (Lys-OMV, second panel), which did not occur if the same OMVs were sonicated prior to pretreatment (third
panel). (B,C) Quantification of P. aeruginosa associated with healthy (non-blotted) murine corneas (B) or superficially injured (blotted) cornea (C) after 1 h ex vivo
pre-incubation with PBS, Lysozyme-induced OMVs (Lys-OMV) and sonicated lysozyme-induced OMVs, followed by 5 h incubation with ∼1011 CFU/ml P. aeruginosa
PAO1-GFP. (D) Average size (µm2 ) of P. aeruginosa aggregates in blotted eyes (measured with Image J) in the same experiment as (C). Data shown are from 4 to 5
fields from each mouse cornea, and are expressed as a median with upper and lower quartiles for each condition. There was no significant difference between
groups in non-blotted corneas, but association differences between groups were significant in blotted corneas (C) ∗ P < 0.04, ∗∗ P < 0.005, but not aggregate size
(D; One-way ANOVA with Tukey’s multiple comparison test). In each instance, a representative experiment is shown of two experiments (non-blotted) and four
experiments (blotted).
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virulence factors capable of cytotoxic effects are associated with
P. aeruginosa OMVs including; protease (elastase), alkaline
phosphatase, phospholipase C, and Cif (Kadurugamuwa and
Beveridge, 1995; Bomberger et al., 2009), although these are
delivered into the host cell cytosol requiring intact OMVs
(Bomberger et al., 2009). In contrast to our data using human
corneal epithelial cells, OMV cytotoxicity toward human airway
epithelial cells required intact OMVs and more time (8 h, vs. 2 h
in the present study; Bomberger et al., 2009). Interestingly, Cif
was not required. Thus, the mechanisms of cytotoxicity observed
for OMVs on corneal epithelial cells in vitro and in vivo may
differ from those affecting airway cells in vitro. Differences in
OMV effects may also reflect differences in other molecules
commonly associated with P. aeruginosa OMVs, e.g., LPS, DNA
(Kadurugamuwa and Beveridge, 1995) or PQS (Pseudomonas
Quinolone Signal; Mashburn and Whiteley, 2005).
In addition to displaying more dead cells at their surface,
previously healthy mouse corneas treated with OMVs in vivo
for 4 h showed an increase in the total number of nuclei at
their surface, and a greater number of cells that had polymorphic
nuclei. This correlated with an increase in Ly6G/C positive
cells at the corneal surface, strongly suggestive of myeloid cell
recruitment after in vivo exposure to OMVs. Whether this
happened directly in response to bacterial components within
OMVs, or indirectly as result of cell injury, is to be determined.
Also unclear is the significance of the result, considering that
myeloid cells play desirable roles in bacterial clearance and
wound healing (Hanlon et al., 2014; Shan et al., 2014), but can
also contribute to inflammation and tissue disruption. Curiously,
many of the Ly6G/C positive cells were similar in size and shape
to corneal epithelial cells (Figure 7A), another finding that will
require further investigation.
Contrasting with the cytotoxic effects of OMVs to the corneal
epithelium, the capacity of OMVs to prime corneal epithelium for
bacterial adhesion required that OMVs were intact. That finding
suggests more than one mechanism of action for OMVs at the
ocular surface, and that OMV delivery of their intravesicular
cargo onto or into host epithelial cells is required for promoting
adhesion.
Mechanisms by which OMVs might enhance susceptibility
to adhesion could include cytosolic delivery of Cif (Bomberger
et al., 2009) which promotes CFTR degradation in lysosomes
(Bomberger et al., 2011). Loss of CFTR decreases P. aeruginosa
internalization by airway and corneal epithelial cells (Pier et al.,
1996; Zaidi et al., 1996) which could cause increased levels
of surface-associated bacteria. More directly, OMV delivery of
proteases and/or phospholipase C could further damage murine
corneal epithelial surfaces to create more sites for bacterial
binding. OMV-mediated increases in P. aeruginosa association
with the cornea could involve facilitation of bacterial aggregation
and biofilm formation as shown for P. putida (Baumgarten et al.,
2012), although our data did not show any differences in the
size or shape of aggregates adhering to the cornea after OMV
exposure.
Why the superficially injured cornea was primed more quickly
for bacterial adhesion is not clear. Possibilities include that
deeper layer cells exposed by blotting were more susceptible,

OMV treatment with PBS controls (Figure 9D; Supplementary
Figures S2D–F). Size distributions of P. aeruginosa aggregates
in each field were also not significantly different among OMV
treatment conditions (data not shown).

DISCUSSION
The results of this study showed that; (1) human tear fluid
and purified lysozyme (but not corneal epithelial cell lysates,
or lactoferrin) induce release of P. aeruginosa-derived OMVs
that have a similar appearance and protein composition to
each other, but not to biofilm harvested OMVs, (2) intact or
disrupted OMVs are cytotoxic toward human corneal epithelial
cells in vitro and to the mouse corneal epithelium in vivo, (3)
intact but not sonicated OMVs increase P. aeruginosa adhesion
to mouse corneas suggesting a mechanism that differs from
their cytotoxic effects and that OMV fusion with the ocular
surface is required, (4) superficial epithelial injury reduces the
time required for OMVs to promote bacterial adhesion, and (5)
OMV exposure increases expression of a myeloid cell marker
at the corneal surface even in an otherwise healthy cornea
in vivo. We also found that (6) P. aeruginosa laboratory and
corneal isolates produce OMVs that vary in appearance and
composition.
While OMV pre-exposure promoted adhesion, the adherent
bacteria were not seen penetrating deeply through the epithelial
multilayer, either in vitro or in vivo. This might be an artifact
due of the relatively short timing or other conditions of these
experiments. Alternatively, OMV exposure is not enough on
its own to enable bacteria to penetrate. Another possibility
is that defenses triggered by OMVs and/or the bacteria that
adhere to the surface counter subsequent bacterial penetration
in our assays. Candidate defenses could include antimicrobial
peptide expression (Augustin et al., 2011), tightening of cell-tocell junctions (Ulluwishewa et al., 2011; Yuki et al., 2011; Kuo
et al., 2013), or NETs (Neutrophil Extracellular Traps) if they
do occur. However, further studies are needed to support this
hypothesis.
Outer membrane vesicles pretreatment reduced the number
of bacteria in the apical compartment of the Transwell chambers
in our in vitro experiments. Whatever the case, anything
that promotes bacterial adherence to the epithelial surface
could increase the probability that bacteria will eventually
penetrate, particularly if other defenses are also compromised.
In this regard, contact lens wear can inhibit innate defense
responses of corneal epithelial cells, including antimicrobial
peptide upregulation in response to P. aeruginosa (Maltseva et al.,
2007).
Lysozyme-induced OMVs were cytotoxic to human corneal
epithelial cells in vitro and mouse corneal epithelium in vivo.
Since sonicated (disrupted) OMVs had the same toxicity as intact
OMVs, the factor(s) involved may be carried externally on the
OMV surface such as LPS as shown previously (Kadurugamuwa
and Beveridge, 1995). While OMV cargo is mostly thought
to be luminal, some factors have been associated with OMV
surfaces, e.g., RNA and DNA (Dorward et al., 1989). Multiple

Frontiers in Microbiology | www.frontiersin.org

15

June 2016 | Volume 7 | Article 871

Metruccio et al.

Tear Fluid Induction of P. aeruginosa OMVs

Taken together, these data may contribute another piece
of the puzzle as to how contact lens wear predisposes to
corneal pathology. Normally, bacteria inoculated into the eye are
quickly cleared, even if introduced in large numbers. However,
P. aeruginosa is able to form biofilms on the posterior surfaces
of contact lenses during wear, at least in rats. On the back of
a worn lens, they would be exposed to sequestered tear fluid
and tear-derived factors that adsorb onto the lens [including
lysozyme (Mannucci et al., 1985; Hall et al., 2014)] for extended
periods of time – potentially long enough to trigger OMV
production. OMVs could also be produced during disinfection
in lens storage cases, and transferred into the eye during lens
insertion. Due to the lack of tear exchange behind a soft
contact lens, OMVs trapped in that location could disrupt
corneal epithelial barrier function against bacteria. The latter
would be in addition to whatever compromise results directly
from lens wear on a cornea, and any live bacteria present.
Since the data also suggest that P. aeruginosa OMVs can
trigger Ly6G/C expression on the surface of the cornea –
suggesting inflammatory cells are present – the results of this
study could also relate to development of “sterile” inflammatory
responses during contact lens wear. At present, the above
scenario represents a theoretical model for OMV involvement in
the pathogenesis of contact lens-related P. aeruginosa keratitis.
However, if substantiated by data from future studies, new lens
care solutions or contact lenses could be developed that minimize
OMV induction by P. aeruginosa, and other Gram-negative
bacteria, and protect the corneal epithelium from OMV mediated
compromise.

that blotting removed extracellular factors protective against
the effects of OMVs (e.g., mucins), or that the mechanism
differs entirely for healthy and superficially injured corneas.
For example, recruitment of Ly6G/C positive cells seen at
the 4 h time point when previously healthy corneas became
susceptible to adhesion might contribute. Indeed, the diffuse
NucGreen staining (not confined to the nucleus) upon bacterial
challenge is suggestive of release of chromosomal DNA
from dead or dying cells (Supplementary Figure S1). This
phenomenon could indicate potential generation of NETs with
longer OMV exposure (Brinkmann et al., 2004; Shan et al.,
2014).
Lysozyme-induced OMVs showed the same banding pattern
as tear-induced OMVs in SDS-PAGE, and were similar in
appearance by TEM. While this suggests that it is the lysozyme
in tear fluid that triggers OMVs, we cannot rule out the
possibility that other tear components participate. Indeed, tear
fluid contains multiple other factors that could be involved,
such as cationic antimicrobial peptides (e.g., α-defensins and
bacterial permeability increasing protein; McDermott et al., 2003;
McDermott, 2009), neutrophils and their products (Sakata et al.,
1997; Zhou et al., 2004; Peuravuori et al., 2006), secretory IgA and
SP-D (Masinick et al., 1997; Ni et al., 2005).
While more research will be needed to determine the
mechanism(s) of OMV induction from P. aeruginosa by tear fluid
and lysozyme, physical mechanisms of membrane disruption
as shown for other OMV inducers are likely to be involved
(Schertzer and Whiteley, 2013). Lysozyme is cationic and disrupts
cell wall peptidoglycan via its muraminidase activity, but also
disrupts outer and cytoplasmic membranes of Gram-negative
bacteria (Pellegrini et al., 1992; Derde et al., 2015). Of possible
relevance, the triggering of P. aeruginosa OMVs by gentamicin
was shown to involve its cationic properties via outer membrane
disruption (Kadurugamuwa and Beveridge, 1997). While the
mechanism by which lysozyme generates OMVs might be similar,
lactoferrin is another cationic agent with bacteriostatic activity
against P. aeruginosa and it did not induce OMV release in our
hands.
Extensive differences in OMV composition were suggested
by SDS-PAGE variations among TSA-grown OMVs released by
different P. aeruginosa strains, and between tear or lysozymeinduced OMVs versus TSA-grown OMVs for strain PAO1.
Growth-related OMV differences could potentially contribute
toward variability between different P. aeruginosa isolates
when interacting with the host. For example, under different
experimental conditions to the present study, cytotoxic, but
not invasive, isolates were found to use OMVs to escape
neutrophil extracellular traps (Shan et al., 2014), yet in the
present study, cytotoxic and invasive isolates could not be
distinguished by TSA-grown OMV patterns. Tear or lysozymeinduced OMVs also appeared more complex than TSA-grown
OMVs for strain PAO1. Further studies, including proteomic
and lipidomic analysis, will be required to delineate differences
in OMVs between stress-induced (tear fluid/lysozyme) and
TSA-grown OMVs in P. aeruginosa, and relate them to
functional differences in their interaction with epithelial
cells.

Frontiers in Microbiology | www.frontiersin.org

AUTHOR CONTRIBUTIONS
MM, DE, MG, JK, and SF designed the experiments. MM
performed the experiments. MM, DE, MG, JK, and SF analyzed
the experiments. MM, DE, and SF wrote the manuscript.

FUNDING
This work was supported by Alcon Research, Ltd., (Johns
Creek, GA) under a research agreement with the University of
California, Berkeley, and by the National Institutes of Health
(EY011221, EY024060, SF).

ACKNOWLEDGMENTS
We thank Ms. Reena Zalpuri (University of California, Berkeley)
for assistance with Electron Microscopy, and Dr. Alison
McDermott (College of Optometry, University of Houston) for
advice on whole mount corneal immunostaining.

SUPPLEMENTARY MATERIAL
The Supplementary Material for this article can be found online
at:
http://journal.frontiersin.org/article/10.3389/fmicb.2016.
00871

16

June 2016 | Volume 7 | Article 871

Metruccio et al.

Tear Fluid Induction of P. aeruginosa OMVs

REFERENCES

Hahn, N., Eisen, R. J., Eisen, L., and Lane, R. S. (2005). Ketaminemedetomidine anesthesia with atipamezole reversal: practical anesthesia for
rodents under field conditions. Lab Anim. 34, 48–51. doi: 10.1038/laban
0205-48
Hall, B., Jones, L., and Forrest, J. A. (2014). Kinetics of competitive adsorption
between lysozyme and lactoferrin on silicone hydrogel contact lenses
and the effect on lysozyme activity. Curr. Eye Res. 40, 622–631. doi:
10.3109/02713683.2014.946518
Hanlon, S. D., Smith, C. W., Sauter, M. N., and Burns, A. R. (2014). Integrindependent neutrophil migration in the injured mouse cornea. Exp. Eye Res. 120,
61–70. doi: 10.1016/j.exer.2014.01.004
Kadurugamuwa, J. L., and Beveridge, T. J. (1995). Virulence Factors Are Released
From Pseudomonas-Aeruginosa in association with membrane-vesicles during
normal growth and exposure to gentamicin - a novel mechanism of enzymesecretion. J. Bacteriol. 177, 3998–4008.
Kadurugamuwa, J. L., and Beveridge, T. J. (1996). Bacteriolytic effect of membrane
vesicles from Pseudomonas aeruginosa on other bacteria including pathogens:
conceptually new antibiotics. J. Bacteriol. 178, 2767–2774.
Kadurugamuwa, J. L., and Beveridge, T. J. (1997). Natural release of virulence
factors in membrane vesicles by Pseudomonas aeruginosa and the effect of
aminoglycoside antibiotics on their release. J. Antimicrob. Chemother. 40,
615–621. doi: 10.1093/jac/40.5.615
Kadurugamuwa, J. L., and Beveridge, T. J. (1998). Delivery of the nonmembrane-permeative antibiotic gentamicin into mammalian cells by using
Shigella flexneri membrane vesicles. Antimicrob. Agents Chemother. 42, 1476–
1483.
Kamiya, H., Ehara, T., and Matsumoto, T. (2012). Inhibitory effects of
lactoferrin on biofilm formation in clinical isolates of Pseudomonas
aeruginosa. J. Infect. Chemother. 18, 47–52. doi: 10.1007/s10156-0110287-1
Katsui, N., Tsuchido, T., Hiramatsu, R., Fujikawa, S., Takano, M., and Shibasaki, I.
(1982). Heat-induced blebbing and vesiculation of the outer membrane of
Escherichia coli. J. Bacteriol. 151, 1523–1531.
Kuo, I.-H., Carpenter-Mendini, A., Yoshida, T., McGirt, L. Y., Ivanov, A. I.,
Barnes, K. C., et al. (2013). Activation of epidermal toll-like receptor 2
enhances tight junction function: implications for atopic dermatitis and
skin barrier repair. J. Invest. Dermatol. 133, 988–998. doi: 10.1038/jid.
2012.437
Macdonald, I. A., and Kuehn, M. J. (2013). Stress-induced outer membrane vesicle
production by Pseudomonas aeruginosa. J. Bacteriol. 195, 2971–2981. doi:
10.1128/JB.02267-12
Maltseva, I. A., Fleiszig, S. M. J., Evans, D. J., Kerr, S., Sidhu, S. S., McNamara,
N. A., et al. (2007). Exposure of human corneal epithelial cells to contact lenses
in vitro suppresses the upregulation of human beta-defensin-2 in response
to antigens of Pseudomonas aeruginosa. Exp. Eye Res. 85, 142–153. doi:
10.1016/j.exer.2007.04.001
Mannucci, L. L., Moro, F., Cosani, A., and Palumbo, M. (1985). Conformational
state of lacrimal proteins adsorbed on contact lenses. Curr. Eye Res. 4, 734–736.
doi: 10.3109/02713688509017675
Mantelli, F., Mauris, J., and Argüeso, P. (2013). The ocular surface epithelial
barrier and other mechanisms of mucosal protection: from allergy to
infectious diseases. Curr. Opin. Allergy Clin. Immunol. 13, 563–568. doi:
10.1097/ACI.0b013e3283645899
Maredia, R., Devineni, N., Lentz, P., Dallo, S. F., Yu, J., Guentzel, N., et al.
(2012). Vesiculation from Pseudomonas aeruginosa under SOS. Sci. World J.
2012:402919. doi: 10.1100/2012/402919
Mashburn, L. M., and Whiteley, M. (2005). Membrane vesicles traffic signals
and facilitate group activities in a prokaryote. Nature 437, 422–425. doi:
10.1038/nature03925
Masinick, S. A., Montgomery, C. P., Montgomery, P. C., and Hazlett,
L. D. (1997). Secretory IgA inhibits Pseudomonas aeruginosa binding to
cornea and protects against keratitis. Invest. Ophthalmol. Vis. Sci. 38,
910–918.
McDermott, A. M. (2009). The role of antimicrobial peptides at the ocular surface.
Ophthalmic Res. 41, 60–75. doi: 10.1159/000187622
McDermott, A. M., Redfern, R. L., Zhang, B., Pei, Y., Huang, L., and
Proske, R. J. (2003). Defensin expression by the cornea: multiple signalling
pathways mediate IL-1beta stimulation of hBD-2 expression by human corneal

Alarcon, I., Kwan, L., Yu, C., Evans, D. J., and Fleiszig, S. M. J. (2009).
Role of the corneal epithelial basement membrane in ocular defense against
Pseudomonas aeruginosa. Infect. Immun. 77, 3264–3271. doi: 10.1128/IAI.00
111-09
Alarcon, I., Tam, C., Mun, J. J., LeDue, J., Evans, D. J., and Fleiszig,
S. M. J. (2011). Factors impacting corneal epithelial barrier function against
Pseudomonas aeruginosa traversal. Invest. Ophthalmol. Vis. Sci. 52, 1368–1377.
doi: 10.1167/iovs.10-6125
Augustin, D. K., Heimer, S. R., Tam, C., Li, W. Y., Le Due, J. M., Evans,
D. J., et al. (2011). Role of defensins in corneal epithelial barrier function
against Pseudomonas aeruginosa traversal. Infect. Immun. 79, 595–605. doi:
10.1128/IAI.00854-10
Bauman, S. J., and Kuehn, M. J. (2006). Purification of outer membrane
vesicles from Pseudomonas aeruginosa and their activation of an IL8 response. Microbes Infect. 8, 2400–2408. doi: 10.1016/j.micinf.2006.
05.001
Baumgarten, T., Sperling, S., Seifert, J., von Bergen, M., Steiniger, F., Wick,
L. Y., et al. (2012). Membrane vesicle formation as a multiple-stress
response mechanism enhances Pseudomonas putida DOT-T1E cell surface
hydrophobicity and biofilm formation. Appl. Environ. Microbiol. 78, 6217–
6224. doi: 10.1128/AEM.01525-12
Beveridge, T. J., Makin, S. A., Kadurugamuwa, J. L., and Li, Z. (1997). Interactions
between biofilms and the environment. FEMS Microbiol. Rev. 20, 291–303. doi:
10.1111/j.1574-6976.1997.tb00315.x
Bloemberg, G. V., O’Toole, G. A., Lugtenberg, B. J., and Kolter, R. (1997). Green
fluorescent protein as a marker for Pseudomonas spp. Appl. Environ. Microbiol.
63, 4543–4551.
Bomberger, J. M., Maceachran, D. P., Coutermarsh, B. A., Ye, S., O’Toole, G. A.,
and Stanton, B. A. (2009). Long-distance delivery of bacterial virulence factors
by Pseudomonas aeruginosa outer membrane vesicles. PLoS Pathog. 5:e1000382.
doi: 10.1371/journal.ppat.1000382
Bomberger, J. M., Ye, S., Maceachran, D. P., Koeppen, K., Barnaby, R. L.,
O’Toole, G. A., et al. (2011). A Pseudomonas aeruginosa toxin that
hijacks the host ubiquitin proteolytic system. PLoS Pathog. 7:e1001325. doi:
10.1371/journal.ppat.1001325
Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D. S.,
et al. (2004). Neutrophil extracellular traps kill bacteria. Science 303, 1532–1535.
doi: 10.1126/science.1092385
Callewaert, L., Aertsen, A., Deckers, D., Vanoirbeek, K. G. A., Vanderkelen, L.,
Van Herreweghe, J. M., et al. (2008). A new family of lysozyme inhibitors
contributing to lysozyme tolerance in gram-negative bacteria. PLoS Pathog.
4:e1000019. doi: 10.1371/journal.ppat.1000019
Chi, B., Qi, M., and Kuramitsu, H. K. (2003). Role of dentilisin in Treponema
denticola epithelial cell layer penetration. Res. Microbiol. 154, 637–643. doi:
10.1016/j.resmic.2003.08.001
Cowell, B. A., Willcox, M. D., and Schneider, R. P. (1997). Growth of gram-negative
bacteria in a simulated ocular environment. Aust. N. Z. J. Ophthalmol. 25(Suppl.
1), S23–S26. doi: 10.1111/j.1442-9071.1997.tb01748.x
Derde, M., Nau, F., Guérin-Dubiard, C., Lechevalier, V., Paboeuf, G.,
Jan, S., et al. (2015). Native and dry-heated lysozyme interactions
with membrane lipid monolayers: lipid packing modifications of a
phospholipid mixture, model of the Escherichia coli cytoplasmic membrane.
Biochim. Biophys. Acta 1848, 1065–1073. doi: 10.1016/j.bbamem.2015.
01.008
Dorward, D. W., Garon, C. F., and Judd, R. C. (1989). Export and intercellular
transfer of DNA via membrane blebs of Neisseria gonorrhoeae. J. Bacteriol. 171,
2499–2505.
Evans, D. J., and Fleiszig, S. M. J. (2013). Why does the healthy cornea resist
Pseudomonas aeruginosa infection? Am. J. Ophthalmol. 155, 961.e–970.e. doi:
10.1016/j.ajo.2013.03.001
Flanagan, J. L., and Willcox, M. D. P. (2009). Role of lactoferrin in the tear film.
Biochimie 91, 35–43. doi: 10.1016/j.biochi.2008.07.007
Frias, A., Manresa, A., de Oliveira, E., Lopez-Iglesias, C., and Mercade, E. (2010).
Membrane vesicles: a common feature in the extracellular matter of coldadapted antarctic bacteria. Microb. Ecol. 59, 476–486. doi: 10.1007/s00248-0099622-9

Frontiers in Microbiology | www.frontiersin.org

17

June 2016 | Volume 7 | Article 871

Metruccio et al.

Tear Fluid Induction of P. aeruginosa OMVs

epithelial cells. Invest. Ophthalmol. Vis. Sci. 44, 1859–1865. doi: 10.1167/iovs.
02-0787
Mun, J. J., Tam, C., Kowbel, D., Hawgood, S., Barnett, M. J., Evans, D. J.,
et al. (2009). Clearance of Pseudomonas aeruginosa from a healthy ocular
surface involves surfactant protein D and is compromised by bacterial
elastase in a murine null-infection model. Infect. Immun. 77, 2392–2398. doi:
10.1128/IAI.00173-09
Murphy, K., Park, A. J., Hao, Y., Brewer, D., Lam, J. S., and Khursigara, C. M.
(2014). Influence of O polysaccharides on biofilm development and outer
membrane vesicle biogenesis in Pseudomonas aeruginosa PAO1. J. Bacteriol.
196, 1306–1317. doi: 10.1128/JB.01463-13
Nagaraju, K., Motukupally, S. R., Garg, P., Sharma, S., Ali, M. H., and
Willcox, M. D. P. (2014). Microbial analyses of contact lens-associated
microbial keratitis. Optom. Vis. Sci. 91, 47–53. doi: 10.1097/OPX.0000000000
000082
Namork, E., and Brandtzaeg, P. (2002). Fatal meningococcal septicaemia
with “blebbing” meningococcus. Lancet 360:1741. doi: 10.1016/S01406736(02)11721-1
Ni, M., Evans, D. J., Hawgood, S., Anders, E. M., Sack, R. A., and Fleiszig, S. M. J.
(2005). Surfactant protein D is present in human tear fluid and the cornea and
inhibits epithelial cell invasion by Pseudomonas aeruginosa. Infect. Immun. 73,
2147–2156. doi: 10.1128/IAI.73.4.2147-2156.2005
Park, A. J., Surette, M. D., and Khursigara, C. M. (2014). Antimicrobial
targets localize to the extracellular vesicle-associated proteome of
Pseudomonas aeruginosa grown in a biofilm. Front. Microbiol. 5:464. doi:
10.3389/fmicb.2014.00464
Pellegrini, A., Thomas, U., von Fellenberg, R., and Wild, P. (1992). Bactericidal
activities of lysozyme and aprotinin against gram-negative and gram-positive
bacteria related to their basic character. J. Appl. Bacteriol. 72, 180–187. doi:
10.1111/j.1365-2672.1992.tb01821.x
Peuravuori, H., Aho, V. V., Aho, H. J., Collan, Y., and Saari, K. M. (2006).
Bactericidal/permeability-increasing protein in lacrimal gland and in tears
of healthy subjects. Graefes Arch. Clin. Exp. Ophthalmol. 244, 143–148. doi:
10.1007/s00417-005-0062-z
Pier, G. B., Grout, M., Zaidi, T. S., and Goldberg, J. B. (1996). How mutant
CFTR may contribute to Pseudomonas aeruginosa infection in cystic fibrosis.
Am. J. Respir. Crit. Care Med. 154, S175–S182. doi: 10.1164/ajrccm/154.4_Pt_
2.S175
Preston, M. J., Fleiszig, S. M., Zaidi, T. S., Goldberg, J. B., Shortridge, V. D., Vasil,
M. L., et al. (1995). Rapid and sensitive method for evaluating Pseudomonas
aeruginosa virulence factors during corneal infections in mice. Infect. Immun.
63, 3497–3501.
Renelli, M., Matias, V., Lo, R. Y., and Beveridge, T. J. (2004). DNAcontaining membrane vesicles of Pseudomonas aeruginosa PAO1 and
their genetic transformation potential. Microbiology 150, 2161–2169. doi:
10.1099/mic.0.26841-0
Robertson, D. M., Li, L., Fisher, S., Pearce, V. P., Shay, J. W., Wright, W. E.,
et al. (2005). Characterization of growth and differentiation in a telomeraseimmortalized human corneal epithelial cell line. Invest. Ophthalmol. Vis. Sci. 46,
470–478. doi: 10.1167/iovs.04-0528
Rumbo, C., Fernández-Moreira, E., Merino, M., Poza, M., Mendez, J. A., Soares,
N. C., et al. (2011). Horizontal transfer of the OXA-24 carbapenemase gene via
outer membrane vesicles: a new mechanism of dissemination of carbapenem
resistance genes in Acinetobacter baumannii. Antimicrob. Agents Chemother.
55, 3084–3090. doi: 10.1128/AAC.00929-10
Sakata, M., Sack, R. A., Sathe, S., Holden, B., and Beaton, A. R. (1997).
Polymorphonuclear leukocyte cells and elastase in tears. Curr. Eye Res. 16,
810–819. doi: 10.1076/ceyr.16.8.810.8992
Schertzer, J. W., and Whiteley, M. (2013). Bacterial outer membrane
vesicles in trafficking, communication and the host-pathogen
interaction. J. Mol. Microbiol. Biotechnol. 23, 118–130. doi: 10.1159/0003
46770
Schooling, S. R., and Beveridge, T. J. (2006). Membrane vesicles: an overlooked
component of the matrices of biofilms. J. Bacteriol. 188, 5945–5957. doi:
10.1128/JB.00257-06
Schooling, S. R., Hubley, A., and Beveridge, T. J. (2009). Interactions of DNA
with biofilm-derived membrane vesicles. J. Bacteriol. 191, 4097–4102. doi:
10.1128/JB.00717-08

Frontiers in Microbiology | www.frontiersin.org

Selinger, D. S., Selinger, R. C., and Reed, W. P. (1979). Resistance to infection of the
external eye: the role of tears. Surv. Ophthalmol. 24, 33–38. doi: 10.1016/00396257(79)90145-0
Shan, Q., Dwyer, M., Rahman, S., and Gadjeva, M. (2014). Distinct Susceptibilities
of Corneal Pseudomonas aeruginosa clinical isolates to neutrophil
extracellular trap-mediated immunity. Infect. Immun. 82, 4135–4143. doi:
10.1128/IAI.02169-14
Singer, J. T., Phennicie, R. T., Sullivan, M. J., Porter, L. A., Shaffer, V. J.,
and Kim, C. H. (2010). Broad-host-range plasmids for red fluorescent
protein labeling of gram-negative bacteria for use in the zebrafish model
system. Appl. Environ. Microbiol. 76, 3467–3474. doi: 10.1128/AEM.01
679-09
Stapleton, F., and Carnt, N. (2012). Contact lens-related microbial keratitis: how
have epidemiology and genetics helped us with pathogenesis and prophylaxis.
Eye (Lond.) 26, 185–193. doi: 10.1038/eye.2011.288
Stapleton, F., and Dart, J. (1995). Pseudomonas keratitis associated with biofilm
formation on a disposable soft contact lens. Br. J. Ophthalmol. 79, 864–865. doi:
10.1136/bjo.79.9.864
Stapleton, F., Dart, J. K. G., Seal, D. V., and Matheson, M. (2009). Epidemiology
of Pseudomonas aeruginosa keratitis in contact lens wearers. Epidemiol. Infect.
114:395. doi: 10.1017/S0950268800052109
Sullivan, A. B., Tam, K. P. C., Metruccio, M. M. E., Evans, D. J., and Fleiszig, S. M. J.
(2015). The importance of the Pseudomonas aeruginosa type III secretion
system in epithelium traversal depends upon conditions of host susceptibility.
Infect. Immun. 83, 1629–1640. doi: 10.1128/IAI.02329-14
Tam, C., LeDue, J., Mun, J. J., Herzmark, P., Robey, E. A., Evans, D. J.,
et al. (2011). 3D quantitative imaging of unprocessed live tissue reveals
epithelial defense against bacterial adhesion and subsequent traversal
requires MyD88. PLoS ONE 6:e24008. doi: 10.1371/journal.pone.00
24008
Tam, C., Mun, J. J., Evans, D. J., and Fleiszig, S. M. J. (2010). The impact of
inoculation parameters on the pathogenesis of contact lens-related infectious
keratitis. Investig. Ophthalmol. Vis. Sci. 51, 3100–3106. doi: 10.1167/iovs.094593
Tan, T. T., Morgelin, M., Forsgren, A., and Riesbeck, K. (2007). Haemophilus
influenzae survival during complement-mediated attacks is promoted by
Moraxella catarrhalis outer membrane vesicles. J. Infect. Dis. 195, 1661–1670.
doi: 10.1086/517611
Thompson, S. S., Naidu, Y. M., and Pestka, J. J. (1985). Ultrastructural localization
of an extracellular protease in Pseudomonas fragi by using the peroxidaseantiperoxidase reaction. Appl. Environ. Microbiol. 50, 1038–1042.
Toyofuku, M., Roschitzki, B., Riedel, K., and Eberl, L. (2012). Identification
of proteins associated with the pseudomonas aeruginosa biofilm extracellular
matrix. J. Proteome Res. 11, 4906–4915. doi: 10.1021/pr300395j
Ulluwishewa, D., Anderson, R. C., McNabb, W. C., Moughan, P. J., Wells,
J. M., and Roy, N. C. (2011). Regulation of tight junction permeability
by intestinal bacteria and dietary components. J. Nutr. 141, 769–776. doi:
10.3945/jn.110.135657
Willcox, M., Sharma, S., Naduvilath, T. J., Sankaridurg, P. R., Gopinathan, U.,
and Holden, B. A. (2011). External ocular surface and lens microbiota
in contact lens wearers with corneal infiltrates during extended wear of
hydrogel lenses. Eye Contact Lens 37, 90–95. doi: 10.1097/ICL.0b013e3182
0d12db
Yonezawa, H., Osaki, T., Kurata, S., Fukuda, M., Kawakami, H., Ochiai, K., et al.
(2009). Outer membrane vesicles of Helicobacter pylori TK1402 are involved in
biofilm formation. BMC Microbiol. 9:197. doi: 10.1186/1471-2180-9-197
Yu, H., and Kim, K. S. (2012). YgfZ contributes to secretion of cytotoxic necrotizing
factor 1 into outer-membrane vesicles in Escherichia coli. Microbiology 158,
612–621. doi: 10.1099/mic.0.054122-0
Yuki, T., Yoshida, H., Akazawa, Y., Komiya, A., Sugiyama, Y., and Inoue, S. (2011).
Activation of TLR2 enhances tight junction barrier in epidermal keratinocytes.
J. Immunol. 187, 3230–3237. doi: 10.4049/jimmunol.1100058
Zaidi, T. S., Fleiszig, S. M., Preston, M. J., Goldberg, J. B., and Pier, G. B. (1996).
Lipopolysaccharide outer core is a ligand for corneal cell binding and ingestion
of Pseudomonas aeruginosa. Invest. Ophthalmol. Vis. Sci. 37, 976–986.
Zhou, L., Huang, L. Q., Beuerman, R. W., Grigg, M. E., Li, S. F. Y., Chew, F. T.,
et al. (2004). Proteomic analysis of human tears: defensin expression after ocular
surface surgery. J. Proteome Res. 3, 410–416. doi: 10.1021/pr034065n

18

June 2016 | Volume 7 | Article 871

Metruccio et al.

Tear Fluid Induction of P. aeruginosa OMVs

Copyright © 2016 Metruccio, Evans, Gabriel, Kadurugamuwa and Fleiszig. This
is an open-access article distributed under the terms of the Creative Commons
Attribution License (CC BY). The use, distribution or reproduction in other forums
is permitted, provided the original author(s) or licensor are credited and that the
original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply
with these terms.

Conflict of Interest Statement: The authors declare that the research was
conducted in the absence of any commercial or financial relationships that could
be construed as a potential conflict of interest.
Dr. Fleiszig was a paid consultant with Allergan Inc. when this work was
performed. That activity was unrelated to the work presented in the manuscript.
Dr. Gabriel and Dr. Kadurugamuwa are paid employees of Alcon Research, Ltd.

Frontiers in Microbiology | www.frontiersin.org

19

June 2016 | Volume 7 | Article 871

